File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1136/heartjnl-2014-306118.93
- WOS: WOS:000359951000094
- Find via
Supplementary
-
Citations:
- Web of Science: 0
- Appears in Collections:
Conference Paper: Ejection fraction by cardiovascular magnetic resonance predicts adverse outcomes post aortic valve replacement
Title | Ejection fraction by cardiovascular magnetic resonance predicts adverse outcomes post aortic valve replacement |
---|---|
Authors | |
Issue Date | 2014 |
Publisher | BMJ Group. The publisher's website is located at http://heart.bmj.com/ |
Citation | The 2014 Annual Conference of the British Cardiovascular Society (BCS), Manchester, UK., 2-4 June 2014. In Heart, 2014, v. 100 suppl 3, p. A53-A54 How to Cite? |
Abstract | Introduction Predicting prognosis following aortic valve replacement (AVR) in patients with aortic stenosis (AS) remains challenging. Current guidelines recommend that surgery should be offered when ejection fraction (EF) is <50%. We sought to investigate the prognostic significance of EF calculated by cardiovascular magnetic resonance (CMR) in the long term survival of patients following AVR.Methods 80 patients (69 ± 11 years old at time of surgery; 55 male) scheduled for AVR underwent CMR assessment. 52 patients had severe AS (area <1cm2), 28 patients had moderate AS (area 1.0–1.5cm2) and other qualifying reasons for AVR. 44 patients had additional coronary artery disease.Patients were categorised into three groups according to EF prior to surgery: Group 1 (EF <50%; n = 26), Group 2 (EF of 50–70%; n = 26) and Group 3 (EF >70%; n = 28). A median 5.0 ± 1.8 years follow-up was completed using the National Strategic Tracing Scheme and hospital notes.Results Univariate analysis of all cause mortality using the Kaplan-Meier estimator demonstrated significantly higher mortality in patients with Group 1 (EF <50%) compared to those in group 3 (EF >70%; .03).There was no statistical difference between group 2 (EF of 50–70%) and the remaining 2 groups.Kaplan-Meier survival curve of all cause mortality in Group 1 (EF <50%), Group 2 (EF 50–70%) and Group 3 (EF >70%)Conclusion Pre-operative EF is a significant predictor of mortality following AVR. Patients with EF <50% have the worst prognosis whereas those with EF >70% have the best prognosis. We aim to incease the sample size to determine whether a progressive decrease in EF per se even when above 50% should initiate consideration for AVR. |
Description | This free journal suppl. entitled: British Cardiovascular Society Annual Conference 2014 02-04 June 2014, Manchester Central, Manchester |
Persistent Identifier | http://hdl.handle.net/10722/216099 |
ISSN | 2023 Impact Factor: 5.1 2023 SCImago Journal Rankings: 1.736 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Vassiliou, V | - |
dc.contributor.author | Chin, C | - |
dc.contributor.author | Perperoglou, A | - |
dc.contributor.author | Tse, G | - |
dc.contributor.author | Ali, A | - |
dc.contributor.author | Raphael, C | - |
dc.contributor.author | Jabbour, A | - |
dc.contributor.author | Newby, D | - |
dc.contributor.author | Pennell, D | - |
dc.contributor.author | Dweck, M | - |
dc.contributor.author | Prasad, S | - |
dc.date.accessioned | 2015-08-24T01:21:16Z | - |
dc.date.available | 2015-08-24T01:21:16Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | The 2014 Annual Conference of the British Cardiovascular Society (BCS), Manchester, UK., 2-4 June 2014. In Heart, 2014, v. 100 suppl 3, p. A53-A54 | - |
dc.identifier.issn | 1355-6037 | - |
dc.identifier.uri | http://hdl.handle.net/10722/216099 | - |
dc.description | This free journal suppl. entitled: British Cardiovascular Society Annual Conference 2014 02-04 June 2014, Manchester Central, Manchester | - |
dc.description.abstract | Introduction Predicting prognosis following aortic valve replacement (AVR) in patients with aortic stenosis (AS) remains challenging. Current guidelines recommend that surgery should be offered when ejection fraction (EF) is <50%. We sought to investigate the prognostic significance of EF calculated by cardiovascular magnetic resonance (CMR) in the long term survival of patients following AVR.Methods 80 patients (69 ± 11 years old at time of surgery; 55 male) scheduled for AVR underwent CMR assessment. 52 patients had severe AS (area <1cm2), 28 patients had moderate AS (area 1.0–1.5cm2) and other qualifying reasons for AVR. 44 patients had additional coronary artery disease.Patients were categorised into three groups according to EF prior to surgery: Group 1 (EF <50%; n = 26), Group 2 (EF of 50–70%; n = 26) and Group 3 (EF >70%; n = 28). A median 5.0 ± 1.8 years follow-up was completed using the National Strategic Tracing Scheme and hospital notes.Results Univariate analysis of all cause mortality using the Kaplan-Meier estimator demonstrated significantly higher mortality in patients with Group 1 (EF <50%) compared to those in group 3 (EF >70%; .03).There was no statistical difference between group 2 (EF of 50–70%) and the remaining 2 groups.Kaplan-Meier survival curve of all cause mortality in Group 1 (EF <50%), Group 2 (EF 50–70%) and Group 3 (EF >70%)Conclusion Pre-operative EF is a significant predictor of mortality following AVR. Patients with EF <50% have the worst prognosis whereas those with EF >70% have the best prognosis. We aim to incease the sample size to determine whether a progressive decrease in EF per se even when above 50% should initiate consideration for AVR. | - |
dc.language | eng | - |
dc.publisher | BMJ Group. The publisher's website is located at http://heart.bmj.com/ | - |
dc.relation.ispartof | Heart | - |
dc.title | Ejection fraction by cardiovascular magnetic resonance predicts adverse outcomes post aortic valve replacement | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Tse, G: tseg@hku.hk | - |
dc.identifier.authority | Tse, G=rp02073 | - |
dc.description.nature | link_to_OA_fulltext | - |
dc.identifier.doi | 10.1136/heartjnl-2014-306118.93 | - |
dc.identifier.volume | 100 | - |
dc.identifier.issue | suppl. 3 | - |
dc.identifier.spage | A53 | - |
dc.identifier.epage | A54 | - |
dc.identifier.isi | WOS:000359951000094 | - |
dc.publisher.place | United Kingdom | - |
dc.identifier.issnl | 1355-6037 | - |